News

Distraction can make you momentarily forget things. But how? Davis lab at Scripps Research, Florida uncovers a mechanism in fruit flies.

How a graduate student’s scientific illustrations have gone viral, leading to an award-winning video series.

Scripps Research President and CEO Peter Schultz, PhD, kicks off the 2021 Front Row lecture series with a talk on how the institute is accelerating drug development. 

Since the team's discovery, several additional cases of the B.1.1.7 coronavirus variant have been identified across California.

A new approach to gene therapy improves the efficiency of gene delivery.

Structural biologists developed the first detailed images of the coronavirus spike protein and then created a way to stabilize the protein for vaccines.  

In addition to addressing age-old questions on origin of life, the finding may lead to new practical applications in chemistry and biology.

The findings may enable better cancer treatments and new interventions for heart disease.

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

The strategy relies on natural cancer-targeting cells of the immune system, called natural killer cells, that have been modified to selectively target lymphoma cells.

A new tool enables scientists to tackle difficult molecular recognition problems to aid drug discovery for incurable diseases.

A pioneering chemist, Yu's research has paved the way to powerful new techniques used in fields ranging from drug discovery to materials science.

The discovery of abnormal chemical reactions may lead to novel targets for drugs that treat neurodegenerative diseases.

More consumers are turning to quick DNA tests to learn their disease risks, but the scores they receive aren't always as precise as they could be.

The researchers on the 2020 list rank in the top 1 percent of citations in their field over the prior decade, as measured by Web of Science, world’s largest publisher-neutral citation index.

Scientists developed an approach that successfully generates antibodies against numerous strains of the fast-evolving human immunodeficiency virus.

In their quest to understand how the immune system is implicated in alcohol use disorder, Scripps Research scientists have found a potential path for treatment. 

With funding from the Centers for Disease Control and Prevention, scientists at Scripps Research and UC San Diego are sequencing the virus to help guide local outbreak response.

A compound designed at Scripps Research works in early tests against myotonic dystrophy 1 and Fuchs endothelial corneal dystrophy, which together affect millions of people.

Sensor data from wearable devices can complement virus testing and conventional screening to signal new infections.

Scientists have uncovered a potential new approach for treating eye diseases that affect millions of people around the world. 

The Louise Hanson Marshall Award honors individuals who significantly promoted the professional development of women in neuroscience.

The monoclonal antibody treatment will be tested in clinical trials, with the goal of reaching patients around the world, including in low- and middle-income countries.    

In rodent experiments modeled to mimic real-life circumstances, scientists revealed brain mechanisms that could lead to targeted treatments.